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Abstract
Introduction The aim of the study was to investigate synovial
immunopathology differences between early Behçet disease
(BD) and psoriatic arthritis (PsA).
Methods Needle arthroscopy of an inflamed knee joint was
performed in patients with early untreated BD (n = 8) and PsA
(n = 9). Synovial fluid (SF) was collected for cytokines, perforin,
and granzyme analysis. Eight synovial biopsies per patient were
obtained for immunohistochemical analysis of the cellular
infiltrate (T cells, natural killer cells, macrophages, B cells,
plasma cells, mast cells, and neutrophils), blood vessels as well
as expression of perforin and granzyme. The stained slides were
evaluated by digital image analysis.
Results The global degree of synovial inflammation was similar
in the two types of arthritis. In the analysis of the innate immune
cell infiltration, there was a striking neutrophilic inflammation in
BD synovitis whereas PsA displayed significantly higher
numbers of cells positive for c-kit, a marker of mast cells. As for
lymphocytes, CD3+ T cells, but neither CD20+ B cells nor
CD138+ plasma cells, were significantly increased in BD versus
PsA. Further analysis of the T-lymphocyte population showed no
clear shift in CD4/CD8 ratio or Th1/Th2/Th17 profile. The SF
levels of perforin, an effector molecule of cytotoxic cells,
displayed a significant four- to fivefold increase in BD.
Conclusions This systematic comparative analysis of early
untreated synovitis identifies neutrophils and T lymphocytes as
important infiltrating cell populations in BD. Increased levels of
perforin in BD suggest the relevance of cytotoxicity in this
disease.
Introduction
Behçet disease (BD) is a systemic inflammatory disorder with
oral and/or genital ulcerations, uveitis, and skin lesions as pro-
totypic clinical symptoms [1]. The systemic nature of the dis-
ease is emphasized by the potential involvement of the central
nervous system, the vascular system, the gut, and the kidney.
Up to half of the patients with BD also display rheumatic fea-
tures. The arthritis is usually monoarticular, intermittent, and
not deforming and affects mainly knees or ankles. Less com-
mon rheumatic features are enthesitis, spondylitis, and sacro-
iliitis. This pattern of rheumatic inflammation as well as the
association with eye, gut, and skin involvement display clinical
similarities with spondyloarthritis (SpA) in general and psori-
atic arthritis (PsA) in particular. Although the pathogenesis of
BD is still poorly understood, the association with class I major
histocompatibility complex molecules (HLA-B51 in BD and
HLA-B27 in SpA) and the response to tumor necrosis factor
(TNF) blockers in both diseases further support the possibility
of common pathophysiological pathways.
Previous studies in psoriatic and non-psoriatic SpA and rheu-
matoid arthritis (RA) have indicated that detailed synovial his-
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molecular immunopathology which are of interest for differen-
tial diagnosis, classification, and pathogenesis of the different
types of arthritis [2-4]. Although joint involvement is clinically
well recognized, few histologic studies have focused on the
synovial features in BD [5-7]. Here, to explore the immunopa-
thology of BD, we performed a detailed comparative study of
early untreated synovitis in BD versus PsA.
Materials and methods
Patients and samples
Eight patients with early untreated BD and nine patients with
early untreated PsA gave written informed consent to partici-
pate in the study as approved by the local ethics committee.
All untreated patients from our early arthritis clinic undergoing
diagnostic or therapeutic knee arthroscopy and fulfilling either
the International Study Group for Behçet's disease criteria for
BD [8] or the CASPAR (classification of psoriatic arthritis) cri-
teria for PsA [9] were included. All BD patients had recurrent
oral and genital aphtosis and folliculitis, five had a positive
pathergy test, two had uveitis, and one developed retinal vas-
culitis. All patients of both study cohorts had early disease (val-
ues of median [range] of disease duration since diagnosis was
made in the early arthritis clinic were 1.0 [0.2 to 7.9] months
in BD and 4.0 [1.7 to 13.5] months in PsA) and were disease-
modifying antirheumatic drug (DMARD)-naïve and corticoster-
oid-naïve. All patients had active joint disease with at least one
swollen knee joint (five monoarthritides and three oligoar-
thritides in BD and two monoarthritides and seven oligoar-
thritides in PsA). Median erythrocyte sedimentation rate
(millimeters per hour) values were 50 (range of 12 to 113) in
BD and 32 (10 to 85) in PsA. Median C-reactive protein (mil-
ligrams per deciliter) values were 6.8 (2 to 15.5) in BD and 2.3
(1.5 to 9.4) in PsA. Needle arthroscopy of the clinically
inflamed knee joint was performed in all patients, with a 2.7-
mm arthroscope (Olympus®; Barcelona, Spain). Synovial fluid
(SF) was collected for cytokine analysis, and eight synovial
biopsies per patient were obtained for immunohistochemical
analysis.
Immunohistochemistry
The synovial biopsies were embedded in paraffin, sectioned,
and subjected to antigen retrieval by cooking when required.
The slides were subsequently stained with an automated
immunostainer (TechMate 500 Plus; Dako, Cambridge, UK)
using the following monoclonal antibodies: anti-CD3 (clone
PS1; Novocastra, Newcastle, UK), anti-CD4 (clone 1F6;
Novocastra), anti-CD8 (clone 4B11; Novocastra), anti-CD20
(clone L26; Dako), anti-CD15 (clone BY87; Novocastra), anti-
CD31 (clone JC70A; Dako), anti-CD56 (clone 123C3; Mon-
osan, Uden, The Netherlands), anti-CD68 (clone KP-1; Dako),
anti-CD117 (mast cells, rabbit anti-human polyclonal antibody;
Dako), anti-CD138 (clone B-B4; Santa Cruz Biotechnology,
Inc., San Diego, CA, USA), anti-granzyme B (clone GrB7;
Monosan), and anti-perforin (clone 5B10; Novocastra). As a
negative control, the primary antibodies were substituted by
isotype- and concentration-matched control antibodies. The
primary antibodies were subsequently detected by an avidin-
biotin-peroxidase-based method (Envision System; Dako) and
an aminoethylcarbazole color reaction (Sigma-Aldrich, St.
Louis, MO, USA) as described previously in detail [2-4,10].
Finally, the slides were counterstained with hematoxylin.
Digital image analysis
The stained slides were scored by digital image analysis by an
independent observer (RC) who was blinded to diagnosis and
clinical data. Each stained slide in its entirety was scored by
dividing it in different regions. Within each region, the number
of stained cells per area as well as the percentage of stained
cells were measured in at least 20 high-power fields using the
AnalySIS® Imaging processing program (Olympus®) as
described previously in detail [11]. The presence of grade-3
lymphoid aggregates, as defined previously [12-15], was
assessed on consecutive sections stained for CD3 and
CD20.
Synovial fluid analysis
SF was collected at the time of arthroscopy for assessment of
total cellular count and number of neutrophils. SF levels of
interferon-gamma (IFN-γ), TNF-α, interleukin (IL)-2, IL-4, IL-6,
and IL-10 were quantified using a multiplex assay in accord-
ance with the instructions of the manufacturer (Cytometric
Bead Assay; BD Biosciences, San Jose, CA, USA). Perforin
(Abcam, Cambridge, UK), granzyme B (Abcam), IL-8 (R&D
Systems, Abingdon, UK), and IL-17 (R&D Systems) levels in
SF were assessed by enzyme-linked immunosorbent assay
(ELISA) as indicated by the manufacturer.
Statistical analysis
Data were analyzed using the SPSS 10.0 statistical program
(SPSS Inc., Chicago, IL, USA). As the data are non-paramet-
ric, they are represented as median (range). Comparisons
were performed with the non-parametric Mann-Whitney U
test. The level of statistical significance was established at a P
value of less than 0.05.
Results
Neutrophilic infiltration in Behçet disease synovitis
The results of the immunohistochemical analysis of the syno-
vial tissue samples are summarized in Table 1. The number of
CD68+ macrophages, which reflects global synovial inflamma-
tion [16], was similar in the intimal lining layer as well as the
synovial sublining of BD and PsA, indicating that there is no
systematic bias in local inflammation between the two study
groups (Figure 1). Further analysis of the synovial leukocyte
infiltration revealed two striking differences between BD and
PsA in non-lymphocytic innate immune populations. First,
there was an important infiltration with CD15+ neutrophils in
BD, representing approximately 13% of the total synovial cel-
lularity compared with approximately 4% in PsA (Figure 1).Page 2 of 7
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tially in the intimal lining layer (P = 0.036 versus PsA), with dif-
ferences that were less pronounced in the synovial sublining.
This prominent neutrophilic infiltration was not related to
higher levels of IL-8, a major chemoattractant for neutrophils,
in BD versus PsA (Table 2). Second, this increase in neu-
trophils was a specific rather than a general phenomenon
related to innate immune cells as the number of cells express-
ing CD117 (c-kit), which is abundantly expressed on mast
cells, was decreased in BD versus PsA (P = 0.046). Finally,
there was no difference in the number of CD31+ blood vessels
between BD and PsA. There were no signs of neutrophilic or
cytoclastic vasculitis.
Accumulation of T lymphocytes in Behçet disease 
synovitis
In the analysis of the lymphocytic infiltration (Table 1), the num-
bers of CD20+ B lymphocytes, lymphoid aggregates, and
large grade-3 aggregates were similar in the two diseases,
with a trend toward lower CD138+ plasma cell numbers in BD
versus PsA (P = 0.071) (Figure 2). In sharp contrast, there
was a threefold increase of CD3+ T lymphocytes in BD versus
PsA (P = 0.015) (Figure 2). Though not statistically significant,
this increase was seen in both the CD4+ and CD8+ T-lym-
phocyte subsets.
Synovial fluid cytokine profiles
As the immunohistochemical analysis indicated a striking dif-
ference in the number of infiltrating T cells between BD and
Figure 1
Microscopic analysis of synovial inflammation with innate immune cells in early untreated Behçet synovitis (BD) versus psoriatic synovitis (PsA). 
Whereas the global degree of synovial inflammation, reflected by the number of CD68+ macrophages, was similar in the two diseases, there were 
significant increases of CD15+ neutrophils in BD and of CD117+ mast cells in PsA. Original magnification ×20.Page 3 of 7
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profile by assessing SF cytokines. As shown in Table 2, BD
and PsA had similar SF leukocyte and neutrophil counts,
reflecting a similar degree of local inflammatory reaction in the
two diseases. This was further confirmed by the similar levels
of IL-6. In an investigation of skewing toward Th1 (IFN-γ, TNF-
α, and IL-2), Th2 (IL-4 and IL-10), or Th17 (IL-17) cytokine pro-
files, only IL-2 showed significantly higher levels in PsA than in
BD (P = 0.017) (Table 2).
Increased synovial fluid perforin levels in Behçet disease
As we observed no clear skewing of the Th1/Th2 profile, we
next investigated whether the infiltrating T cells displayed fea-
tures of cytotoxic cells. CD56, a marker expressed by cyto-
toxic T cells and natural killer (NK) cells, was slightly but not
significantly increased in BD versus PsA (Figure 2). Immunos-
taining of perforin and granzyme B, both cytotoxic effectors,
showed only few positive cells without differences between
BD and PsA (Table 1), but the SF levels of perforin showed a
highly significant four- to fivefold increase in BD (1,168 pg/mL,
range 428 to 2,010 pg/mL) versus PsA (278 pg/mL, range
132 to 642 pg/mL) (P = 0.005) (Table 2). The SF levels of
granzyme were below the detection limit of the ELISA in all
samples.
Discussion
Although BD is a relatively common and potentially severe sys-
temic disease, the pathophysiology of the disease remains
poorly understood. Microbial infections, sterile neutrophil-
mediated inflammation, and autoimmune lymphocytes have all
been implicated in the recurrent attacks of inflammation char-
acteristic of this disease [1], leading to an ongoing debate on
the autoimmune versus autoinflammatory origin of BD [17]. As
we and others demonstrated previously that detailed analysis
of the histopathology of the target lesions can yield important
pathophysiological information in rheumatic conditions [2-
4,10], we took advantage here of the predilection of the dis-
ease for knee joints and the availability of biopsy sampling by
needle arthroscopy to revisit in detail the synovial immunopa-
thology of BD. None of the arthroscopies, performed primarily
for diagnostic and/or therapeutical reasons, leads to cutane-
ous or joint complications, including pathergy-like reactions
[18]. This observation indicates that it is medically and ethi-
cally acceptable to perform histology studies in BD.
Table 1
Immunohistochemical analysis of synovial tissue biopsies from early untreated Behçet disease and psoriatic arthritis
Behçet disease Psoriatic arthritis P value
n = 8 n = 9
Synovial immunopathology (cells/mm2)
CD68 lining 3,681 (877–6,831) 2,947 (541–4,834) NS
CD68 sublining 529 (311–2,339) 739 (183–2,636) NS
CD3 1,077 (354–1,427) 336 (164–1,036) 0.015
CD4 516 (31–1,306) 196 (3–1,061) NS
CD8 524 (2–832) 113 (3–669) NS
CD20 126.5 (61–703) 106 (38–510) NS
Lymphoid aggregates 0.93 (0.34–6.8) 0.43 (0–3.04) NS
Grade-3 lymphoid aggregates 0.08 (0–1.38) 0 (0–0.44) NS
CD138 45 (11–432) 173 (8–1,490) 0.071
CD56 17 (1–144) 9 (2–77) NS
Granzyme B 12 (2–93) 9 (2–20) NS
Perforin 8.5 (3–26) 6 (1–22) NS
CD15 lining 919 (101–4,436) 275 (11–1,015) 0.036
CD15 sublining 305.5 (31–1,050) 203 (25–467) NS
CD117 60 (21–286) 162 (29–365) 0.046
CD31 (vessels/mm2) 80 (60–255) 133 (63–166) NS
After immunostaining of paraffin or frozen sections, the number of positive cells per square millimeter was assessed by digital image analysis. Data 
are presented as median (range). NS, non-significant.Page 4 of 7
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time the histology of synovitis in six BD patients [5]. That study
found no evidence of infection but a dense mixed inflammatory
infiltrate with the prominent presence of neutrophils and scar-
city of plasma cells in most samples. Similarly, a second study
found a paucity of plasma cells in 12 BD synovial tissues but
did not describe the presence of neutrophils [7]. Strikingly,
they found ectopic lymphoid neogenesis, defined as the devel-
opment of large lymphoid aggregates resembling secondary
lymphoid organs [12-15], in 5 out of 12 samples. Unfortu-
nately, the interpretation of both data sets is hampered by the
inclusion of patients with long disease duration and the lack of
a control group with non-BD synovitis. Including RA synovial
tissue as control, a third study could not confirm the prominent
infiltration with neutrophils or any other distinctive feature in
seven BD cases but indicated that the findings may be influ-
enced by the longer disease duration [6]. The present study
was designed to overcome the limitations of these previous
analyses by systematic comparison with a clinically related
inflammatory arthritis, PsA, and by stringent selection of active,
early, and untreated disease for both groups. As local disease
activity is an important determinant of synovial histopathology
[10], this design additionally allowed us to match BD and PsA
for local disease activity as measured by SF cell count, SF IL-
6 levels, and synovial tissue CD68+ macrophage numbers
[16]. As such, this stringent study design obviously limits the
number of cases that can be included but minimizes the risk of
systematic biases and false-positive findings.
In the analysis of the infiltrating leukocytes from the innate
immune system, a first striking feature of BD synovitis was the
marked infiltration with polymorphonuclear neutrophil (PMN).
This neutrophilic infiltration cannot be explained by disease
duration as both BD and PsA had very early, untreated dis-
ease. It was also not related to a difference in levels of IL-8, a
major chemokine for PMN. Moreover, this increase did not
extend more broadly to innate immunity in general as cells pos-
itive for the mast cell marker CD117 appeared to be
decreased in BD versus PsA. This relative increase in BD ver-
sus PsA most likely reflects a true increase in BD as previous
studies showed that the number of infiltrating PMN was
already high in PsA compared with RA synovial tissue [3,4].
Increased numbers of PMN in BD inflammation have been
reported not only in synovium [5] but also in other target
organs such as skin [19,20] and the central nervous system
[21]. Moreover, the function of PMN has been reported to be
altered in BD [22,23]. Taken together, these data are consist-
ent with a prominent role of PMN in the disease process and
may suggest some degree of similarity between the patho-
physiology of the synovitis and skin reactions such as the
pathergy test in BD. In contrast, however, we did not find any
evidence for neutrophilic vasculitis or any other form of vessel
pathology in the synovial tissue. Synovitis is thus clearly differ-
ent from cutaneous lesions in this respect as leukocytoclastic
vasculitis is a prominent feature of skin lesions in BD [24,25].
Table 2
Synovial fluid analysis in early untreated Behçet disease and psoriatic arthritis
Behçet disease Psoriatic arthritis P value
n = 8 n = 9
Cells/mm3 15,840 (7,600–30,720) 15,000 (2,250–35,500) NS
Neutrophils/mm3 10,865 (4,200–28,000) 10,000 (562–23,450) NS
Percentage neutrophils 72.5 (53.75–91.15) 74.07 (24.98–94) NS
IL-6 8,850 (6,484–12,157) 8,678 (6,107–11,022) NS
IL-8 272 (115–4,500) 241 (102–3,033) NS
TNF-α 13.5 (9–44) 11 (0.1–32) NS
IFN-γ 103.5 (9–323) 89 (62–134) NS
IL-2 26.5 (9–34) 38 (31–78) 0.017
IL-4 80.5 (66–111) 86 (77–107) NS
IL-10 17.5 (5–22) 10 (2–28) NS
IL-17 <25 <25 NS
Perforin 1168 (428–2,010) 278 (132–642) 0.005
Granzyme B <15 (<15–56) <15 (<15–41) NS
The cytokines as well as perforin and granzyme B were detected by enzyme-linked immunosorbent assay and are expressed as picograms per 
milliliter. Data are presented as median (range). IFN-γ, interferon-gamma; IL, interleukin; NS, non-significant; TNF-α, tumour necrosis factor-alpha.Page 5 of 7
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ovial T lymphocytes in BD. Again, this was specific for T cells
rather than related to a global increase in lymphocyte infiltra-
tion as we found similar numbers of B lymphocytes and a sim-
ilar degree of organization in lymphoid aggregates in both
diseases. Moreover, previous studies showed no difference in
T-cell infiltration between PsA and RA, suggesting that the
increase in BD is actually specific [3,4]. Confirming previous
studies on BD synovitis [5,7], plasma cells were even lower in
BD versus PsA synovitis. Although we did not investigate the
mechanism underlying the selective increase in T lym-
phocytes, previous studies indicated that BD T cells are par-
tially protected against apoptosis [26]. Moreover, a recent
report indicates that specific T-cell subsets are associated
with sterile neutrophil-rich inflammation as observed in BD
synovitis, which may explain the simultaneous increase of both
T cells and PMN [27].
As to the potential functional contribution of these T cells to
the pathology, both Th1 skewing [28,29] and cytotoxicity by
classical CD8+ cells, NK T cells, or gamma-delta cells [28-30]
have been proposed. Our SF analysis failed to demonstrate a
clear Th1 skewing, with lower IL-2, but not for IFN-γ and TNF-
α, levels in BD versus PsA. There was also no significant dif-
ference in the number of CD8+, CD56+, perforin+, or granzyme
B+ cells, defining cytotoxic cells, in BD versus PsA synovitis.
However, the levels of perforin released in the SF were fivefold
increased in BD versus PsA, suggesting the relevance of cyto-
toxicity in BD synovitis [30-32].
Conclusion
This systematic comparative analysis of early untreated syno-
vitis identifies both lymphocytes and PMN as important infil-
trating cell populations and indicates an increase of cytotoxic
molecules in BD versus PsA. Further studies should clarify
their functional contribution to the pathogenesis of the dis-
ease.
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